United States · 
Who invested in Access Vascular?
Access Vascular's investors include MedTech Innovator and AngelMD.
201820192020202120222023
$3.7MRound$6.0MRound$22MSeries CUnited States · Series C startup
Who invested in Access Vascular
3 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$32Mraised across 3 rounds since 2017, from 3 sources
$3.7MRound$6.0MRound$22MSeries C
- Latest round
- Series C, $22MOct 2023
- Step-upi
- 3.7×
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $3.7M Aug 2017
- Biggest round
- $22M Series C · Oct 2023
- Usual gap between rounds
- 4 years the median of 2
The rounds
- Oct 2023
- Sept 2019Round$6.0M
No investor was named in the report.
Reported by FinSMEsSEC filing: $5.6M sold, first sale Aug 2019
- Aug 2017
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Access Vascular
How much has Access Vascular raised?
Access Vascular has raised $32M across 3 rounds since 2017.
When did Access Vascular last raise?
Access Vascular's most recent round was a Series C of $22M in Oct 2023.
What was Access Vascular's biggest round?
Its most recent round, $22M in Oct 2023, is also its largest on record.
Who backed Access Vascular first?
Access Vascular's first round on record, in Aug 2017, was backed by AngelMD.
What stage is Access Vascular at?
Access Vascular's latest named round is a Series C, in Oct 2023.
Where is Access Vascular based?
Access Vascular is based in the United States.
Companies like Access Vascular
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.